COST-UTILITY OF USTEKINUMAB IN THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN COLOMBIA

被引：0
|
作者：
Ojeda, C. [1 ]
Hernandez, N.
Giraldo, C., V [2 ]
Argote, A. C. [3 ]
Coronell, S. [4 ]
Roa, M. [5 ]
机构：
[1] Hosp La Samaritana, Bogota, Colombia
[2] Univ El Bosque, Bogota, Colombia
[3] Hosp San Jose, Bogota, Colombia
[4] Cafesalud Colmed, Bogota, Colombia
[5] Janssen Cilag, Bogota, Colombia
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.506
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSS16
引用
收藏
页码：A124 / A124
页数：1
相关论文
共 50 条
  • [21] Cost Effectiveness of Moderate to Severe Psoriasis Therapy with Etanercept and Ustekinumab in the United States
    Villacorta, Reginald
    Hay, Joel W.
    Messali, Andrew
    [J]. PHARMACOECONOMICS, 2013, 31 (09) : 823 - 839
  • [22] Cost Effectiveness of Moderate to Severe Psoriasis Therapy with Etanercept and Ustekinumab in the United States
    Reginald Villacorta
    Joel W. Hay
    Andrew Messali
    [J]. PharmacoEconomics, 2013, 31 : 823 - 839
  • [23] Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasis
    Martin, Silas
    Feldman, Steven R.
    Augustin, Matthias
    Szapary, Philippe
    Schenkel, Brad
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2011, 22 (03) : 138 - 143
  • [24] Cost per responder with adalimumab versus ustekinumab treatment for moderate to severe psoriasis with suboptimal response to etanercept
    Augustin, Matthias
    Sundaram, Murali
    Mulani, Parvez M.
    Bao, Yanjun
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB189 - AB189
  • [25] Spotlight on Ustekinumab in Moderate To Severe Plaque Psoriasis
    Croxtall, Jamie D.
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2012, 13 (02) : 135 - 137
  • [26] Mixed treatment comparison of infliximab with ustekinumab in patients with moderate to severe psoriasis
    Fan, T.
    Bennett, H.
    Smith, N.
    Marin, M.
    Shuvayu, S.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (06) : E38 - E39
  • [27] Ustekinumab: Treatment of Adult Moderate-to-Severe Chronic Plaque Psoriasis
    Scanlon, James V.
    Exter, Benjamin P.
    Steinberg, Michael
    Jarvis, Courtney I.
    [J]. ANNALS OF PHARMACOTHERAPY, 2009, 43 (09) : 1456 - 1465
  • [28] Efficacy and safety of ustekinumab in the treatment of moderate to severe plaque psoriasis in Singapore
    Chan, Wai Sze Agnes
    Wong, Yisheng
    Oon, Hazel Hwee Boon
    Theng, Colin Thiam Seng
    Chong, Wei-Sheng
    [J]. SINGAPORE MEDICAL JOURNAL, 2023, 64 (07) : 434 - 438
  • [29] Spotlight on Ustekinumab in Moderate To Severe Plaque Psoriasis
    Jamie D. Croxtall
    [J]. American Journal of Clinical Dermatology, 2012, 13 : 135 - 137
  • [30] Biologics for severe, chronic plaque psoriasis: An Australian cost-utility analysis
    Sun, Helen Y.
    Keller, Elena
    Suresh, Harish
    Sebaratnam, Deshan F.
    [J]. JAAD INTERNATIONAL, 2021, 5 : 1 - 8
12345